The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: pravastatin sodium     Quarter: 2016Q3

Total Drug/Injury Combinations: 118     Number of Pages: 6

DRUGNAME PT EventCount
PRAVASTATIN SODIUM. Malaise 1 view events
PRAVASTATIN SODIUM. Migraine 1 view events
PRAVASTATIN SODIUM. Myocardial infarction 1 view events
PRAVASTATIN SODIUM. Nausea 1 view events
PRAVASTATIN SODIUM. Oxygen saturation decreased 1 view events
PRAVASTATIN SODIUM. Palpitations 1 view events
PRAVASTATIN SODIUM. Platelet count decreased 1 view events
PRAVASTATIN SODIUM. Product use issue 1 view events
PRAVASTATIN SODIUM. Renal failure 1 view events
PRAVASTATIN SODIUM. Renal tubular necrosis 1 view events
PRAVASTATIN SODIUM. Restless legs syndrome 1 view events
PRAVASTATIN SODIUM. Suicidal ideation 1 view events
PRAVASTATIN SODIUM. Surgery 1 view events
PRAVASTATIN SODIUM. Therapeutic response unexpected 1 view events
PRAVASTATIN SODIUM. Toxicity to various agents 1 view events
PRAVASTATIN SODIUM. Transaminases increased 1 view events
PRAVASTATIN SODIUM. Tremor 1 view events
PRAVASTATIN SODIUM. Vomiting 1 view events

Total Drug/Injury Combinations: 118     Number of Pages: 6

NOTE: EventCount numbers on this page include duplicate entries from event reports. (e.g. One event has DrugX entered twice, which equals 2 on this page.) The "view events" page treats these duplicates as single entries. (e.g. The 2 entries of DrugX for a single event are counted as 1 instance.)